Evidence map›Paper›PMID 32739321›Full record

ArticleBlood cells, molecules & diseases2021

Corrigendum to "Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database" [Blood Cells, Molecules and Diseases (2020) Start page-End page/202438].

Hezekiah Isa, Samuel Adegoke, Anazoeze Madu, Abdul-Aziz Hassan, Chinatu Ohiaeri, Reuben Chianumba, Biobele Brown, Emmanuel Okocha, Ngozi Ugwu, Ijeoma Diaku-Akinwumi and 20 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Blood cells, molecules & diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Hezekiah IsaCentre of Excellence for Sickle Cell Disease Research & Training, University of Abuja (CESRTA), Abuja, Federal Capital Territory, Nigeria.
Samuel AdegokeDepartment of Paediatrics, Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria.
Anazoeze MaduDepartment of Haematology, University of Nigeria Teaching Hospital, Enugu, Nigeria.
Abdul-Aziz HassanDepartment of Haematology and Blood Transfusion, Ahmadu Bello University, Zaria, Nigeria.
Chinatu OhiaeriDepartment of Paediatrics, Federal Medical Centre, Keffi, Nigeria.
Reuben ChianumbaCentre of Excellence for Sickle Cell Disease Research & Training, University of Abuja (CESRTA), Abuja, Federal Capital Territory, Nigeria.
Biobele BrownDepartment of Paediatrics, University College Hospital, Ibadan, Nigeria.
Emmanuel OkochaDepartment of Haematology, Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria.
Ngozi UgwuDepartment of Haematology, Federal Teaching Hospital, Abakaliki, Nigeria.
Ijeoma Diaku-AkinwumiDepartment of Paediatrics, Lagos State University Teaching Hospital, Lagos, Nigeria.
Titilope AdeyemoDepartment of Haematology, Lagos University Teaching Hospital, Lagos, Nigeria.
Aisha Kuliya-GwarzoDepartment of Haematology, Aminu Kano University Teaching Hospital, Kano, Nigeria.
Livingstone DogaraDepartments of Haematology and Paediatrics, Kaduna State University Teaching Hospital, Kaduna, Nigeria.
Haliru LawalDepartments of Haematology and Paediatrics, Kaduna State University Teaching Hospital, Kaduna, Nigeria.
Yohanna TankoCentre of Excellence for Sickle Cell Disease Research & Training, University of Abuja (CESRTA), Abuja, Federal Capital Territory, Nigeria.
Adama LaduDepartment of Haematology, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria.
Umar KangiwaDepartment of Haematology, Federal Medical Centre, Birnin Kebbi, Kebbi State, Nigeria.
Lilian EkwemDepartment of Paediatrics, General Hospital Nyanya, Federal Capital Territory, Nigeria.
Seyi OniyangiDepartment of Paediatrics, National Hospital Abuja, Nigeria.
Tambi WakamaDepartment of Haematology, National Hospital Abuja, Nigeria.
Dominic UmoruDepartment of Paediatrics, Maitama District Hospital FCT, Abuja, Nigeria.
Olaniyi OlanrewajuDepartment of Haematology, Ambrose Alli University, Irrua, Edo State, Nigeria.
Norah AkinolaDepartment of Haematology, Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria.
Uchenna Nnebe-AgumaduDepartment of Paediatrics, University of Abuja Teaching Hospital, Abuja, Nigeria.
Samuel AsalaCentre of Excellence for Sickle Cell Disease Research & Training, University of Abuja (CESRTA), Abuja, Federal Capital Territory, Nigeria.
Adekunle AdekileDepartment of Paediatrics, Kuwait University, Kuwait.
John OlaniyiDepartment of Haematology, University College Hospital, Ibadan, Nigeria.
Raphael SangedaDepartment of Pharmaceutical Microbiology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Sickle Africa Data Coordinating Center (SADaCC)SADaCC, Division of Human Genetics, Faculty of Health Science, University of Cape Town, Cape Town, South Africa.
Obiageli NnoduCentre of Excellence for Sickle Cell Disease Research & Training, University of Abuja (CESRTA), Abuja, Federal Capital Territory, Nigeria. Electronic address: obiageli.nnodu@uniabuja.edu.ng.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32739321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.